World Cell and Gene Therapy Summit South Korea

South Korea is rapidly advancing its cell and gene therapy (CGT) ecosystem, with key milestones such as Curocell’s Rimqarto becoming the first MFDS-approved cell therapy, and continued innovation from companies like Vaxcellbio and Rznomics advancing next-generation modalities. More recently, breakthroughs in in vivo CAR therapies, enhanced LNP and AAV delivery platforms, and advanced manufacturing have accelerated development timelines in the clinic.

Date and Time: Tuesday, 10 November 2026 at 08:30 – Thursday, 12 November 2026 at 15:15

Venue details: Grand Hyatt Incheon, 208 Yeongjonghaeannam-ro 321beon-gil, Jung-gu, Incheon, 22382, Korea (South)

Prices:
USD 1749.00 – USD 5149.00